Its predicted that Novo Nordisks Ozempic will be the second top-selling drug of 2024, with projected sales exceeding $16 billion US dollars
Since Ro exited compounded GLP-1s in 2026, its lowest effective monthly cost is approximately $298/month for the FDA-approved Wegovy pill ($149/month medication + $149/month required Ro Body Membership), rising to $348/month for the Wegovy pen and $448/month for Zepbound
In one study, older individuals with a history of chronic constipation were more than three times as likely to develop Parkinsons disease during an average 5.5 years of follow-up, and those with the most severe constipation had the greatest risk (Lin 2014)
Healthspan shouldnt be brand-first, and it shouldnt be vanity-metric-first either
These are the observable outcomes ordered by when they typically appear
Patients with a history of depression, anxiety disorders, bipolar disorder, or previous suicidal thoughts warrant closer monitoring during GLP-1 treatment, as these pre-existing conditions represent the most significant risk factors for suicidal ideation